ArticleJournal of cancer research and clinical oncology2022
Trastuzumab treatment of patients with early, HER2-positive breast cancer in 17 certified German breast cancer centers.
Nora Tabea Sibert et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.